Immunome, Inc. (IMNM) Net margin 2023–2025
Immunome, Inc. (IMNM) net profit margin by fiscal year — reported net income divided by reported revenue.
-3060.0%FY2025 · since FY2023: -761.9% → -3060.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -3060.0% | +180.4 pp |
| FY2024 | -3240.4% | -2478.5 pp |
| FY2023 | -761.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More IMNM financial trends
IMNM RevenueIMNM Net incomeIMNM Gross profitIMNM Gross marginIMNM Operating incomeIMNM Operating marginIMNM Operating cash flowIMNM Free cash flowIMNM Capital expendituresIMNM Return on equityIMNM Stock buybacksIMNM Dividends paidIMNM Total assetsIMNM Total liabilitiesIMNM Shareholders’ equityIMNM overview →